Article
US FDA approves AstraZeneca's breast cancer drug combination
Rating:
0.0
Views:
61
Likes:
1
Library:
1
The U.S. Food and Drug Administration on Thursday approved AstraZeneca's Truqap in combination with an older drug, providing another treatment option for patients with the most common type of breast cancer.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value